BioMérieux
BioMérieux Q2 Revenues Rise 5 Percent
The firm confirmed its 2023 full-year guidance for revenue to increase between 4 percent and 6 percent.
Siemens Healthineers, Thermo Fisher, Becton Dickinson, Roche Gain FDA Clearances in June
The June 510(k) clearances included a von Willebrand antigen test, a bilirubin assay, antimicrobial susceptibility tests, and infectious disease tests.
Top Five Articles on 360Dx Last Week: Siemens Healthineers Layoffs and Atellica Focus; and More
Last week, readers were most interested in a story about changes at Siemens Healthineers as it plans to shut down some of its legacy instruments.
BioMérieux Gets CLIA Waiver for BioFire SpotFire Respiratory Panel Mini
The CLIA waiver now allows the SpotFire system and two existing panels to be used by non-lab professionals at the point of care, the firm said.
BioMérieux Q1 Revenues Rise 8 Percent
The firm saw revenue growth across almost all business divisions, with a 32 percent jump in BioFire portfolio sales.